Drug Type Trispecific antibody |
Synonyms TB-535H, TB535 |
Target |
Mechanism 5T4 inhibitors(Trophoblast glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Biotecnol Ltd.Startup |
Active Organization- |
Inactive Organization Biotecnol Ltd.Startup |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | GB | Biotecnol Ltd.Startup | 10 Aug 2017 |